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The Indiana Chronic Disease Management Program (ICDMP) is intended to
improve the quality and cost-effectiveness of care for Medicaid members with
congestive heart failure (chronic heart failure), diabetes, asthma, and other con-
ditions. The ICDMP is being assembled by Indiana Medicaid primarily from
state and local resources and has seven components: (1) identification of eligible
participants to create regional registries, (2) risk stratification of eligible partic-
ipants, (3) nurse care management for high-risk participants, (4) telephonic
intervention for all participants, (5) an Internet-based information system,
(6) quality improvement collaboratives for primary care practices, and (7) pro-
gram evaluation. The evaluation involves a randomized controlled trial in two
inner-city group practices, as well as a statewide observational design. This ar-
ticle describes the ICDMP, highlights challenges, and discusses approaches to
its evaluation.
Key Words: Disease management, quality improvement, diabetes, Medicaid.
The spiraling costs and substandard quality ofchronic illness care have elicited an array of efforts to redesignits delivery (Lozano et al. 2003; Rothman and Wagner 2003).
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These efforts include paying incentives to physicians who meet quality
goals (Epstein, Lee, and Hamel 2004), reshaping individual practices by
cultivating the chronic care model (Wagner et al. 2001), and applying
that model in large-scale disease management programs (Bodenheimer,
Wagner, and Grumbach 2002a; Finkelstein et al. 2002; Villagra 2004;
Wheatley 2001). The chronic care model involves six areas of change:
(1) community resources and policies, (2) health care organization, (3)
self-management support, (4) delivery system design, (5) decision sup-
port, and (6) clinical information systems (Bodenheimer, Wagner, and
Grumbach 2002a). Implementation of the model has been effective in
some settings but has produced mixed or ineffective results in others
(Bodenheimer, Wagner, and Grumbach 2002b; Coleman et al. 1999;
Olivarius et al. 2001; Schonlau et al. 2005; Solberg et al. 2000).
Attracted by the promise of lower costs and better quality of care,
large payers and purchasers are turning increasingly to chronic dis-
ease management programs (Gold and Kongstvedt 2003; Wilson 2003;
Smith 2003). The focus is often on high-risk patients. However, the
programs’ overall effectiveness may be greater if they also attend to the
wider, moderate- to low-risk population—those with less complicated
illness (Cook et al. 1995; Rose 1992). State Medicaid agencies urgently
need to improve care and control costs (Rosenbaum 2002). After an un-
usual period of sound finances in the late 1990s, latent forces reemerged
(Iglehart 2003; Weil 2003): Medicaid agencies faced growing numbers
of eligible members, rising costs of medical care, and pressure from state
legislatures, themselves in budget crises, to rein in expenditures.
In the past decade, more than twenty state Medicaid agencies in-
stituted disease management programs. Some states contracted with
commercial disease management vendors, while other state programs
used a combination of commercial and homegrown elements (Faulkner
2003; National Conference of State Legislatures 2003; Wheatley 2001;
Gillespie and Rossiter 2003). Even though vendors promise a large re-
turn on investment (Groeller and Silva 2003), high-quality studies of the
cost-effectiveness of disease management programs have shown mixed
results. Therefore, much more study is needed if the vendors’ claims
are to be supported (Bodenheimer, Wagner, and Grumbach 2002b;
Fireman, Bartlett, and Selby 2004; Office of Program Policy Analy-
sis and Government Accountability 2004; Rothman and Wagner 2003;
Wilson 2003). In addition, some vendor programs have been controver-
sial. In one state, a pharmaceutical company took up a Medicaid disease
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management program and simultaneously obtained preferred status on
the Medicaid formulary (Groeller and Silva 2003).
Several states have chosen a combination of commercial and local
approaches. In 2001, the program Florida: A Healthy State was imple-
mented jointly by a pharmaceutical company subsidiary and the Florida
Agency for Health Care Administration. The largest Medicaid disease
management initiative to date, it enrolled more than 150,000 Floridians
with diabetes, congestive heart failure (chronic heart failure), asthma, or
hypertension. Intensive care management was provided for a high-risk
subpopulation (approximately 19,000 people) identified by analyzing
claims data. Care managers were based in ten catchment areas centered
on hospitals throughout the state, and high-risk participants outside
these ten areas were contacted by an out-of-state telephone center run by
a commercial disease management vendor (White et al. 2005). To date,
evaluation of the program has produced inconclusive or even conflicting
results (Florida Agency for Health Care Administration 2004; Office of
Program Policy Analysis and Government Accountability 2004). Other
states also are combining disease management vendor services with state-
coordinated services. Mississippi contracted with a commercial vendor
to establish an in-state, nurse-staffed telephone center. This program
collaborated with local partners, including the University of Mississippi
Medical Center, the Mississippi Primary Health Care Association and its
Community Health Centers, and a vendor that provides field-based nurse
care management (Crowder 2003). Mississippi’s program also contained
an innovative component, led by pharmacists, to provide drug therapy
management for patients with diabetes or asthma (Young 2003). Other
states, such as Texas (for its Medicaid members with diabetes), required
their Medicaid managed care organizations to offer disease management
services; West Virginia implemented a state-led (Bureau of Public Health
and the Bureau of Medicaid Services) disease management program for
its Medicaid members with diabetes or asthma (Association of State and
Territorial Health Officials 2002).
In Indiana, the Medicaid director, Melanie Bella, and the state health
commissioner, Dr. Gregory Wilson, first considered proposals from dis-
ease management vendors in response to a state-issued request but ulti-
mately decided instead to assemble their own program, primarily from
state and local resources. Vendors emphasized the money they could
save, but their programs were nonetheless expensive, delivered several
of the key components of chronic disease management services from
138 Marc B. Rosenman et al.
out-of-state centers, and, if implemented, seemed unlikely to signifi-
cantly enhance the capabilities of Indiana’s existing systems of care. A
state-assembled program, it was reasoned, would be challenging to build
and implement but might offer the potential for sustained, large-scale
changes within Medicaid and other systems in Indiana. Such a pro-
gram could incorporate activities typical of disease management ven-
dors, centered outside of the medical care system, but also could advance
the chronic care model in physician practice (Casalino 2005). In testi-
mony before the U.S. House of Representatives, Director Bella outlined
the objectives of the Indiana Chronic Disease Management Program
(ICDMP):
• “Provide higher quality care to Medicaid recipients that improves
health status, enhances quality of life and teaches self-management
skills.
• Provide support to primary care providers and integrate primary
care with case management.
• Utilize and strengthen the public health infrastructure.
• Reduce the overall cost of providing health care to Medicaid patients
suffering from chronic diseases.
• Achieve long-term results by changing the way primary care is
delivered across the state, not just for Medicaid.” (Bella 2003)
The Indiana leadership also opted for a rigorous evaluation of the
ICDMP. A partnership was developed with the Regenstrief Institute,
Inc., a medical informatics and health services research institute affiliated
with the Indiana University School of Medicine, to provide technical
consultation and to design and conduct the evaluation. The authors of
this report are the ICDMP consultants and evaluators at the Regenstrief
Institute. The Institutional Review Board of Indiana University-Purdue
University Indianapolis approved the Regenstrief Institute’s activities in
the ICDMP.
Following the Indiana state legislature’s direction, the Office of
Medicaid Policy and Planning (OMPP) launched the ICDMP on July 1,
2003, for eligible participants with diabetes or congestive heart failure
(CHF). The ICDMP was implemented in stages. The central third of the
state began ICDMP activities in July 2003. The northern and south-
ern thirds of Indiana, as well as a statewide asthma disease management
program, were added during 2004. The program’s implementation was
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staggered regionally for logistical reasons, to facilitate hiring and train-
ing personnel, and for efficient outreach to physicians and participants.
Diabetes, CHF, and asthma were selected because of their prevalence,
morbidity and mortality, costs to the state, and the potential effective-
ness of a disease management initiative for these conditions.
The state also staggered the program’s implementation in two large
urban group practices, to enable comparison between participants who
became eligible for ICDMP services in 2003 with contemporaneous con-
trols who would become eligible approximately eighteen months later.
One of these two large urban group practices is home to the Regenstrief
Medical Records System (RMRS), a state-of-the-art electronic medical
record that includes diagnoses, laboratory results, progress notes, dis-
charge summaries, vital signs, and a computerized physician order entry
system (McDonald et al. 1999; Tierney et al. 2003). The RMRS would
prove valuable, along with Medicaid administrative data, in the devel-
opment and evaluation of the ICDMP.
This article focuses on the ICDMP for adults with diabetes and/or
CHF. We first describe the main components of a large-scale disease
management program and discuss some of Indiana’s innovative ap-
proaches in assembling them. Then we look at several of the developmen-
tal hurdles faced by an “assemble-rather-than-buy” initiative. Finally,
we outline the planned evaluation and highlight some of its inherent
challenges.
Program Components and Assembly
In a state that buys a complete Medicaid disease management initiative
from a vendor, responsibility for shaping the initiative probably rests
largely with the vendor. In contrast, a state that assembles its own dis-
ease management initiative must spend considerable energy and time
designing and planning: building consensus, reviewing what other pay-
ers have tried, analyzing in-state data, exploring policy options, creating
materials and tool kits, awarding contracts for each of the program’s
components, and guiding and coordinating the contractors’ activities.
During the winter and spring of 2003, the Chronic Disease Advisory
Council, led by the Indiana state health commissioner, drew up con-
sensus guidelines for the primary care of diabetes and congestive heart
failure. A two-day ICDMP planning meeting was convened in March
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2003 by the Medicaid director and the health commissioner, with the
MacColl Institute of Seattle as the facilitator. In addition to the state
agencies and the MacColl Institute’s national expert panel, the planners
included the developers of the guidelines, the programmers of the in-
formation system, the leaders of organizations that would provide the
nurse care management and telephonic care management services, and
representatives from the Indiana University School of Medicine and the
Regenstrief Institute. Work groups (each about eight to twelve people)
were then formed to design the ICDMP’s components. The work groups
covered the identification and risk stratification of eligible participants,
nurse care management, telephonic care management, the information
system, and the design of educational materials for patients. The work
groups were composed of Indiana Medicaid and Department of Health
staff, the contractors that would provide each service, and management
consultants. Each work group included at least one adviser from the
Regenstrief Institute. These groups met throughout the spring of 2003,
and the components that they developed are described next and are de-
picted in Figure 1.
Identification of Participants and Creation of
Regional Registries
Shortly before the beginning of the ICDMP, Indiana Medicaid introduced
a managed care program (Medicaid Select) for its aged/blind/disabled
Medicaid population. Medicaid Select is not risk-based managed care
(RBMC); rather, it is primary care case management (PCCM), in which
each member’s primary medical provider (PMP) receives a $4 monthly
fee to coordinate care and referrals. The member’s health care otherwise
is reimbursed on a fee-for-service basis. About 60,000 (8 percent) of the
800,000 people in Indiana Medicaid are in Medicaid Select. Since the
mid-1990s, Indiana Medicaid also has had a combined PCCM/RBMC
program, called Hoosier Healthwise, for its much larger (N = 525,000)
income-eligible and SCHIP (State Children’s Health Insurance Program)
populations, primarily women and children. More than 85 percent of the
ICDMP’s participants with diabetes or CHF are members of the state’s
aged/blind/disabled (Medicaid Select) program, a population that tends
to be less mobile and to have more continuous enrollment in Medicaid.
More than 40 percent of the participants with diabetes or CHF have dual
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figure 1. Components of the ICDMP.
Medicaid/Medicare eligibility. The Indiana Medicaid leadership speci-
fied Medicaid Select or Hoosier Healthwise membership as a prerequisite
for participation in the ICDMP. Accordingly, the ICDMP excludes peo-
ple in nursing homes or other “waiver” eligibility categories—settings
in which, it is hoped, integrated care is already provided. For the same
reason, the ICDMP also excludes members in risk-based managed care.
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The initial selection of participants with a particular illness requires
readily available data. Automated queries of Medicaid claims were cre-
ated to identify people with diabetes or CHF, based on relevant Inter-
national Classification of Diagnosis (ICD-9) codes or disease-specific
prescriptions in the previous year. The queries are repeated approxi-
mately every three to six months in order to find eligible participants
not previously identified. These condition-specific lists of participants,
sorted by the PMPs’ practice location and county, constitute the regional
registries of ICDMP eligibles. Participants are enrolled according to the
selection criteria and are informed by mail of their ICDMP eligibility,
although they may opt out. Participants also may become ineligible for
various reasons, such as if they move into a nursing home, into a waiver
category, or into risk-based managed care, or if they cannot be contacted
after multiple attempts.
The first stage of the ICDMP began in July and August 2003 for
thirty-two central Indiana counties (including Indianapolis) and en-
rolled approximately 4,500 adults who were identified as having di-
abetes and/or CHF (the vast majority had diabetes). Among these 4,500
people identified and assigned to ICDMP, about 11 percent opted out
and another 15 percent otherwise became ineligible during the first two
years of the program.
Risk Stratification
Risk stratification was performed in order to assign ICDMP-eligible
participants to different program services. In the ICDMP context, “risk”
refers to the likelihood of a participant’s higher or lower utilization of
health services in the next year, and the cost of these services to Indiana
Medicaid. Cost-prediction models were created and validated for Indiana
Medicaid members with diabetes and/or CHF (Li et al. 2005). Based in
part on empirical cost distributions for its populations with chronic
illnesses, Indiana decided to assign nurse care managers to the highest-
risk 20 percent of eligible participants with CHF or diabetes, while
telephone care coordinators would focus on the lowest-risk 80 percent of
participants. (The mean prior-year costs for the high-risk 20 percent were
at least five times higher than those for the low-risk 80 percent of par-
ticipants.) After completion of the nurse care management intervention,
the high-risk participants transitioned to telephonic care management.
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The nurse care management and telephone care management services are
described later.
Stratification and service prioritization involve estimating a risk score
for each participant and choosing a threshold for assignment to high- or
low-intensity care management. The stratification algorithm was devel-
oped using two years of retrospective claims data: a hypothetical disease
management cohort was created using data from year 1; candidate pre-
dictors from year 1 were modeled against costs in year 2 to create a
parsimonious risk stratification algorithm for adults with CHF and/or
diabetes. Of the many candidate predictors modeled, the final algorithm
involved three predictors: total net Medicaid claims costs in the past year,
Medicaid aid category (e.g., the beta-weight for the “disabled” category
was higher than that for the “aged” category), and total number of unique
medications filled in the past year (Li et al. 2005).
After comparing various algorithms, the Regenstrief Institute consul-
tants recommended that for ICDMP’s purposes, the most relevant metric
was not R2 but classification efficiency: minimizing mismatches in a
3 × 3 table of observed versus predicted costs. The 3 × 3 table catego-
rized individuals into the highest 20 percent, the next 30 percent, and
the lowest 50 percent of predicted and observed costs. Because the cost-
effectiveness of a disease management initiative depends partly on how
well it targets high-intensity intervention to those participants most in
need, we tried to minimize the number of people with high predicted and
low observed costs, or vice versa. In the future, the Indiana policymakers
and the Regenstrief Institute team will consider enhanced stratification
algorithms that incorporate self-reported data that the ICDMP is col-
lecting by telephone on all program participants. Useful items might
include self-rated health, expected health care utilization in the next
year, or whether or not a participant named an individual doctor as his
or her primary source of care.
Nurse Care Management for the
Highest-Risk Participants
ICDMP-funded nurse care managers educate their patients, encourage
self-management, facilitate their communication with physicians, and
make referrals to community resources. Before visiting a participant,
the nurse care managers typically begin by contacting the primary care
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physician and collecting data from the patient’s medical record. The
data elements are based on the Indiana guidelines, for example, for dia-
betes, the dates and results of the most recent A1C test, blood pressure,
lipid profile, urine microalbumin test, fundoscopic eye exam, and lower
extremity monofilament test, as well as the dates of the most recent
office visit, dental visit, flu shot, and pneumococcal vaccine. The nurse
care manager is then in a position to encourage the participants and
the physicians to follow the guideline-recommended schedules for these
activities.
At home visits, the nurse care managers establish a relationship, as-
sess needs, and help participants set self-management goals. After home
visits, the nurses usually work with the participants by phone, although
in urban areas more than one home visit may be feasible. The Indiana
Office of Medicaid Policy and Planning (OMPP) encourages the nurses
to accompany participants to at least one doctor visit. The nurses do not
manage medications under protocol or otherwise act in a direct clini-
cal capacity. Rather, they provide educational support and activation,
using self-management goal sheets and “stages of change” (Prochaska
and DiClemente 1982) protocols developed or adapted for the ICDMP.
The nurses encourage participants to maintain their supply of medicine
and their adherence to physician-directed treatment plans. The nurses
also encourage them to eat wisely and exercise, not smoke, and make
and keep appointments with the PMP. The self-management goals for
participants with diabetes include good foot care and self-monitoring of
glucose levels, and, for participants with CHF, a low-sodium diet and
daily weight measurement. Using the eight-item Patient Health Ques-
tionnaire (PHQ-8) (Kroenke, Spitzer, and Williams 2001), the nurses
can screen participants for depression and then notify the PMP about
those with scores indicating a high risk.
The nurses must be hired and trained for these care management
roles, and effective coordination with the telephonic care management
center (described in the next section) must be developed. The OMPP
contracted with the Indiana Minority Health Coalition and the Indiana
Primary Health Care Association to provide nurse care management
services, with each county assigned to one organization. The nurses
carry a tool kit—developed by the OMPP, the Indiana State Depart-
ment of Health (ISDH), and collaborators—containing guidelines, self-
management protocols, and educational and motivational materials. The
nurse care management organizations give the state monthly reports on
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the nurses’ caseloads and the participants’ progress in self-management.
In the first nine months of the program, nurse care managers made an
initial telephone contact with approximately 40 percent of the 1,100
high-risk participants in central Indiana who had been identified in the
claims data. A smaller percentage completed a home visit and then a full
period of engagement with a nurse care manager. The nurse care man-
agers visited the PMPs’ offices to review the written medical records of
most of the high-risk participants.
After approximately six months of interacting with a participant,
the nurse completes a discharge summary, which is recorded in the in-
formation system. The telephone center then follows up with two brief
scripted calls, two and six weeks later. The nurse care manager selects the
topics for these calls, such as nutrition planning, diabetes medicines, self-
monitoring of blood glucose, and making and keeping appointments.
After these brief follow-up calls, the participants enter the queue of full-
length outbound educational and motivational calls that the telephone
center makes to other participants (described later).
Telephonic Care Management for All
Participants
Some disease management programs are entirely telephonic; a stratified
approach involving both nurse and telephonic care management affords
a variety of design options. In the ICDMP, those participants not under
nurse care management receive telephonic care management. Trained
nonclinical personnel, the “care coordinators,” supervised by a regis-
tered nurse, call participants quarterly, if possible. The telephone call
scripts are designed by the Regenstrief Institute, in collaboration with
the telephone center, and are designed to stimulate self-care, encour-
age the provision of core medical care, and offer educational resources.
The care coordinators use the ICDMP information system software (de-
scribed in more detail later), which supports outbound telephone calls
with a branching structure—tailored to the participant’s responses—and
storage of multiple-choice and free text responses for future analysis.
Scripts with condition-specific branches were created for four inter-
actions between the telephone care coordinators and the participants, as
well as for the follow-up calls made to those who recently completed
a period of interaction with a nurse care manager. National and state
evidence-based guidelines for the care of persons with diabetes and CHF
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were used to identify the content of the telephone “curriculum.” Motiva-
tional interviewing constructs (Emmons and Rollnick 2001), health care
literacy concerns, and field testing shaped the scripts’ diction. The first
diabetes and CHF telephone call begins with solidarity-building and
then turns to general questions about the participants’ health and care.
Flu shots are encouraged. The next calls make increased use of scripted,
tailored dialogues. The second call focuses on medicine supply and adher-
ence and encourages participants to keep a list of their medicines and to
bring it to their PMP visits. At one point, the participant is asked to leave
the telephone, to gather his or her medicines, and then to return; the care
coordinator times this activity to gauge how much difficulty the partic-
ipant had. Using scripted advice, the care coordinators discuss problems
the participants might have had in obtaining their medicine or in taking
it. This call also includes questions and messages about foot care, blood
glucose monitoring, aspirin use, weight checks, exercise, smoking, and
depression. The third and fourth calls offer a choice of topics, such as
diet, physical activity, and preventing complications. Those topics not
selected for one call are deferred to subsequent calls. The telephone cen-
ter can mail ICDMP-designed low-literacy educational materials and a
one-page, individualized summary of key points that were discussed,
encouraging the participant to bring the summary to his or her next
visit to the doctor.
The OMPP contracts for telephone care management services with
its PCCM (primary care case management) administrator. This firm was
already running a telephone center providing enrollment assistance to
Medicaid members and PMPs. Several of the ICDMP telephone care
coordinators were transferred from that call center and trained for their
new role. The telephone center also responds to calls from participants,
provides administrative support for the nurse care managers (e.g., helps
them reach a participant), and makes referrals to community resources
(e.g., for transportation).
Information System
An information system can contribute in various ways to chronic disease
management. At a minimum, it serves as a central list of the selected and
stratified participants. At its best, an information system provides deci-
sion support—making treatment guidelines available at the point of care
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(for clinicians or nurse care managers)—plus advanced registry functions
such as clinical reminders and performance feedback for providers. For the
ICDMP, the Indiana team adapted and augmented a Web-based system,
CDMS (Chronic Disease Management System), which was developed by
the Montana Medicare Quality Improvement Organization.
In the ICDMP, CDMS maintains a central list of participants who
are assigned to nurse care management or telephonic care management.
Indiana Medicaid’s fiscal agent flags the ICDMP participants in its own
system and sends nightly updates of eligibility information to CDMS.
CDMS gives the nurse care managers their own lists and enables them to
enter and retrieve data, care plans, and progress notes. The templates for
the care plans and progress notes reflect the Indiana consensus guidelines
and the ICDMP’s self-management goal sheets for each chronic illness.
The ICDMP created an elaborate CDMS telephone-center application to
support the outbound, individualized telephone calls just described. It
also maintains queues of calls scheduled quarterly, tracks each partici-
pant’s call history, stores his or her responses to each item, and records
the purpose of any inbound calls. CDMS continues to be modified in
order to meet the program’s needs: the linkage between the nurse care
management and the telephone center applications is being strength-
ened to enable a nurse care manager to view a participant’s telephone
call responses, and a telephone care coordinator to view relevant data
recorded by the nurse care manager.
The CDMS’s clinical office application, a Web-based disease man-
agement registry that is used by several primary care practices in the
western United States, was offered free of charge by the state of Indiana
to any practice that wished to adopt it. The ICDMP offered the CDMS
training, Web-based demonstrations, and a help desk for practices. Ide-
ally, a system like CDMS in clinical offices would provide not only
decision support and registry functions within the office but also a way
to exchange data between the office and the nurse care managers or tele-
phone center. However, this long-term vision of data integration has not
yet been realized. Only one clinical office in Indiana has implemented
CDMS completely. A few other practices, in their ongoing quality im-
provement activities, have made use of the program’s eligibility lists
stored in CDMS by the ICDMP administrators. The long-term hope is
for a centralized information system to incorporate data from the of-
fices’ own billing systems, as well as from claims files from the Indiana
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Medicaid fiscal agent; the software and data would drive decision support
and clinical reminders at multiple points of care.
Practice Change and Quality Improvement
Collaboratives for Primary Care Practices
Quality improvement that supports planned and integrated care in
office practice is an essential ingredient in the chronic care model
(Bodenheimer, Wagner, and Grumbach 2002a). Promoting it for thou-
sands of clinicians statewide is not easy; merely promoting guidelines is
not enough (Cabana et al. 1999). One approach is to invite practices to
participate in quality improvement collaboratives. The OMPP and ISDH
conduct these collaboratives, based on the model for quality improve-
ment in chronic care (Kilo 1999). The first series, focused on diabetes
and CHF, began in June 2003 for approximately twenty practices in
central Indiana. Five of the twenty were clinical sites within the Indiana
University Medical Group. Many of the others were federally qualified
health centers (FQHCs). These twenty practices provide primary care
for approximately 15 percent of the aged/blind/disabled Medicaid pop-
ulation in central Indiana. Three new collaborative series were begun
in 2004; they covered all regions of the state and focused on care for
children with asthma as well as for adults with diabetes or CHF. Most of
the participating practices were community health centers or FQHCs.
The participating practices set quality improvement goals and reported
their performance once a month. Ideas were also shared during monthly
conference calls and through an email listserve. Indiana University sub-
specialists answered general educational questions from providers by
email or during conference calls. The nurse care managers and telephone
center leaders also attended the collaborative learning sessions.
The primary care collaboratives extend to only those practices that
can be recruited to attend. The ICDMP also seeks to improve quality
throughout Indiana. Provider tool kits—containing clinical guidelines
and educational material for clinicians, and self-management and edu-
cational tools for patients—are mailed to all primary medical providers
in the state who see Medicaid patients. Any of these practices (if there
is an ICDMP-eligible participant on its patient panel) may be contacted
by an ICDMP nurse care manager or telephone care coordinator or may
encounter patients who have been engaged by the nurse care managers
or telephone care coordinators.
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Challenges in Program Development
Once the OMPP made the “assemble-rather-than-buy” decision, it
needed to contract for new elements of a delivery system (telephone
care coordinators and field-based nurse care managers) to enhance and
strengthen the care of Indiana’s Medicaid members with chronic ill-
nesses. The OMPP was accustomed to acting as a payer, but creating and
managing part of the delivery system itself were breaking new ground.
The Regenstrief Institute, an academically affiliated research organiza-
tion, needed to be both a support unit for program development and
an evaluator. This kind of work is often at the mercy of the program’s
exigencies. In contrast to the typical, deliberative, “scientific labora-
tory” mission of an academic organization largely supported by external
grants, this work tends to focus on making good use, quickly, of the best
immediately available information.
Assembling the Registry: Knowing Who Is
Eligible for the Program
There are many ways to define a registry using administrative data. In
the ICDMP, the inclusion criteria for diabetes were an ICD-9 code for
diabetes or a prescription claim for diabetes medicine or supplies in the
past year; CHF was defined as an ICD-9 code for CHF or prescriptions
for both digoxin and a loop diuretic during the past year, but different
definitions may also be reasonable. The first telephone call serves as an
additional eligibility check: people are simply asked whether they have
diabetes or CHF. Using their responses as the “gold standard,” the ad-
ministrative data query had a positive predictive value of approximately
95 percent for diabetes and 90 percent for CHF. In addition to the defini-
tional challenge, creating a list of eligible participants may be technically
complicated. With large, complex data systems, multiple iterations may
be required to hone the list. Two different databases were available in the
ICDMP for cross-checking or validation: (1) a second Indiana Medicaid
administrative data warehouse and (2) the Regenstrief Medical Records
System (RMRS). The former, jointly maintained by Indiana Medicaid
and a vendor, offered a combination of data warehouse and analytic
functions; it received its statewide data directly from Indiana Medicaid’s
fiscal agent and then provided additional processing (merged tables, ag-
gregated variables, etc.). Midway through the ICDMP’s first two years,
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the OMPP replaced its second data warehouse with a different system,
from a new vendor. The RMRS data were available for a large group
practice in Indianapolis, which included the majority of participants in
the randomized controlled trial component of the evaluation. A related
difficulty was the tie between eligibility for disease management and
prerequisite eligibility for aged/blind/disabled or other primary care case
management programs, which are not static. As a result of such complex-
ity, disease management databases and their links with other Medicaid
program data must be regularly kept up to date.
Risk Stratification: Identifying Who Is Most
Likely to Benefit
Focusing intensive interventions on those with highest risk makes in-
tuitive sense, but a program’s effects on health and cost-effectiveness
will be even greater if the intensive services are extended to those par-
ticipants who can actually benefit from them. The best way to predict
who is most likely to benefit has not yet been discovered. The ICDMP’s
approach thus far is to stratify based on expected costs in the next year.
The telephone calls provide an additional opportunity to move partici-
pants from the low-risk to the high-risk (nurse care management) group.
The telephone center’s nurse supervisor may refer a participant to the
nurse care management organizations if he or she seems confused or dis-
organized during telephone contacts or at the request of a primary care
physician. During the first year of the program, nineteen participants
were transferred to nurse care management in this way. As the ICDMP
evolves, the risk-stratification methods might expand. We are exploring
various additional approaches, which identify participants who have poor
self-rated health, who have recently been to the hospital or emergency
department, who are running out of critical medicines, and/or who have
a new claim for a sentinel prescription.
Nurse Care Management: Guiding a Critical
Function That Is Not Easily Observed
The success of a multifaceted disease management program may rest on
whether its nurse care managers work effectively with high-risk partic-
ipants and their physicians. While nurse care management is critical to
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the systems approach to chronic care, it is not easily observed, supported,
and improved, because much of the nurses’ activity takes place in the
field (visiting patients and interacting with physicians in widely dis-
persed practice sites). Quality control is difficult to achieve, particularly
when two different organizations are providing the services. In some
ways, however, it is an advantage to have two different organizations,
with differing styles and approaches, as the OMPP and ISDH continue
to shape the delivery of nurse care management. One challenge is how
much of the nurse care management should take place in the home in-
stead of by telephone. Home visits can mean substantial travel time and
costs, especially in rural areas.
Telephonic Care Management and Vulnerable
Populations: Designing Effective
Education/Motivation Tools
The population served by the ICDMP is quite ill, with one-third of the
adults with CHF or diabetes self-rating their health as “poor.” Coexist-
ing illnesses are common, and literacy is low. Many of the educational
and motivational tools for this population, including the telephone call
scripts, had to be developed anew. In addition, it can be difficult to reach
the eligible population by telephone and to keep them in the program.
After ten months of activity by the telephone center, two-thirds of the
initial cohort of adults with CHF or diabetes had successfully completed
the first telephone script. Many of the others could not be reached. But
when participants were reached, most found the calls helpful. Ninety-
seven percent of those with diabetes or CHF who completed the third call
described it as helpful; they appreciated the specific content areas and/or
just that someone cared enough to call to discuss their health. Clearly,
maintaining access to this vulnerable population to deliver supplemental
services is a challenge that has not been fully resolved.
Information Systems: Overcoming Technical and
Other Barriers to Widespread Acceptance
Even under the best of circumstances, a new information system
might not be welcomed by busy physician practices (Bodenheimer and
Grumbach 2003). The ICDMP information system’s slow connectiv-
ity and real-time operation discouraged its adoption. Group practices
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that already had electronic medical record systems were reluctant to
“double-enter” data into a new system. In addition, building an auto-
mated interface between two electronic systems requires a lot of time
and resources. In the ICDMP, software development for telephone and
nurse care management was the principal focus of the programmers.
An outreach and help-desk effort was made to encourage some primary
care clinicians to adopt the CDMS office interface. But only one clinical
office in Indiana has adopted CDMS completely, and a few other prac-
tices are using part of it. A very small staff of CDMS programmers in
the ICDMP had to build an extensive new telephone-center application,
adapt existing CDMS functions for use in nurse care management and
in the ICDMP registries, and ensure appropriate data privacy, all while
helping interested office practices with start-up and troubleshooting.
Sometimes these priorities prevented the permanent storage of all data
elements. The long-term vision—a centralized information system of-
fering decision support, reminders, and provider feedback to clinical
practices, as well as integration with nurse care management and tele-
phonic data—has not yet been realized.
Collaboratives and Other Aspects of Quality
Improvement in Clinical Practice: Achieving
and Sustaining Results
A fundamental challenge involves improving quality in certain settings
and then spreading these gains statewide. Participation in a quality
improvement collaborative requires an investment, especially of time.
Community health centers reacted more favorably than private practices
to the collaborative invitations, and even with maximal turnout, the
collaboratives would involve only a fraction of practices in the state.
Despite the introduction of a new billing code for group patient visits,
it has proved difficult for the collaboratives to stimulate such visits.
Practices can resent mandates from large commercial insurers or state
agencies. New interactions between nurse care managers and physicians
can be dissonant, despite efforts by the Regenstrief and Indiana Medicaid
ICDMP teams to improve the nurse care managers’ “academic detailing”
skills (Soumerai and Avorn 1990). (Academic detailing is another way
to influence the practice behaviors of primary care clinicians. It is mod-
eled on pharmaceutical face-to-face salesmanship [“detailing”]. What is
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marketed, however, is not a pharmaceutical product but evidence-based
clinical practice, and, in the ICDMP context, the promotion of patient
self-management and the chronic care model.) The OMPP and ISDH
conducted extensive outreach and sent provider tool kits statewide to
every primary care practice that sees Medicaid patients. The ICDMP
probably has not affected the statewide rate at which physicians partici-
pate in Medicaid itself. There have been a number of reported successes in
coordinated interaction among participants, physicians, and nurse care
managers or telephone care coordinators, but spreading quality improve-
ment and “planned care” throughout the state is an ongoing challenge.
There is one overarching challenge—to create sufficient capacity for
implementing programs widely. The management tasks in assembling
a new program like the ICDMP are complex. State Medicaid agencies
have limited management capacity to create and run unprecedented new
delivery programs (Thompson 1998). Budgets are limited; existing per-
sonnel are fully committed to existing programs; and time is short,
given the legislative pressures for performance. The state government’s
relatively small staff must wrestle with huge volumes of complex data
for many programs (not just the ICDMP). One of Indiana’s strengths
was the farsighted leadership of both the state legislature and the
executive branch officials who developed the ICDMP. In many other
states, disease management programs are being pressed to demonstrate
cost savings within a fixed, short, time. In Indiana, both branches of
government recognized the ICDMP’s need to develop and grow before
better health outcomes could be translated into cost savings. This sup-
portive environment cultivated self-management, health promotion, and
quality improvement as the primary goals, with (eventual) cost savings
as a secondary consideration.
Program Evaluation and Its Challenges
Most disease management program evaluations involve observational
designs. Their results can be contaminated by regression to the mean,
temporal trends, or other less quantifiable biases. The ICDMP’s evalu-
ation was designed to avoid these biases, using both observational and
randomized components: an observational comparison of the central,
northern, and southern regions of Indiana; and a randomized controlled
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trial in two large urban group practices. The randomized trial, it is
hoped, will help us identify and measure biases that could arise in the
observational designs. The staggered implementation statewide permits
an observational analysis of time intervals before and after each regional
start date: a repeated measures design with boundary analysis. We will
control as much as possible for secular and seasonal trends, geographic
and practice variation, regression to the mean, and maturity of the disease
management program.
The staggered implementation of the CHF and diabetes program in
two urban group practices allowed a randomized comparison between
participants who started in 2003 and those who started in 2005. Alloca-
tion was by clinic site: the largest clinic was randomly allocated to 2003
versus 2005; the others were then allocated one by one, by minimizing
the between-group difference in number of participants. Participants
with primary medical providers at the 2003-start sites became eligible
for nurse care manager and telephone center services during the summer
of 2003 (the “ICDMP” group); those with PMPs at the 2005 sites be-
came eligible during mid-2005 (the “abeyance” group). Providers and
staff from the 2003 sites were invited to the 2003/04 ICDMP quality
improvement collaborative, and those at the 2005 sites could be invited
to a 2005/06 collaborative, if one is held.
General Design Vulnerabilities: Power and Bias
A randomized trial in the midst of a rapidly implemented, larger-scale
initiative faces all the usual challenges, plus some extras. The staggered
implementation in two large group practices made possible the random-
ized controlled trial. But even in the state’s largest group practice, the
size of each arm (ICDMP and abeyance) was modest. The number of par-
ticipants (and the statistical power) depended largely on the statewide,
policy-driven inclusion and exclusion criteria and on the extent to which
the nurse care managers and telephone care coordinators reached those
who were eligible. There was no recruitment period to extend.
Other challenges include those associated with allocating individual
Medicaid participants to each arm by clinical site (by cluster). Some
participants moved between primary care sites during the evaluation
period. In both the trial and the statewide time-series there can be bias
from secular trends in costs and quality of care. With regional start
dates scattered throughout the year, seasonal variation is an important
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consideration, but it will be controlled as much as possible by assessing
pre-ICDMP variation across several years of longitudinal data.
The Nature of the Interventions: Moving
Targets and Crowded Playing Fields
Disease management interventions must be adaptive and continuously
improve: move or get “run over” (Finkelstein et al. 2002). An academ-
ically affiliated support team can suggest adaptations, such as a new
systematic, timely intervention for participants prescribed a sentinel
medicine, or extra training to help build the nurse care managers’ aca-
demic detailing skills. A key challenge for the evaluation is that all
ICDMP interventions and adaptations take place in the context of other,
ongoing, practice improvement activities. In a large, urban group prac-
tice, these activities include randomized trials of other interventions,
enhancements to information or electronic order-entry (Gopher) sys-
tems, and smaller-scale initiatives to improve clinical documentation.
The ICDMP also takes its place amid other Medicaid benefits and el-
igibility policies, which themselves are not static. In these shifting,
crowded playing fields, it might be impossible for the evaluation team
to understand the full extent of activities outside the ICDMP, to isolate
the effects of the ICDMP, or to “credit” the ICDMP for practice changes
that it induces indirectly.
Time Frame and Horizon: What Durations
Are Sufficient?
The best time frame (duration of the intervention) and time horizon
(follow-up of the program’s effectiveness) for an evaluation are not clear.
How long does a new telephonic service unit require before the services it
offers are mature? How long should a nurse care manager work with each
participant before turning to others? How many years are required before
the effects of chronic disease management (e.g., the prevention of diabetes
complications) are realized? A particular difficulty for the preliminary
evaluation is that a disease management program needs time to become
fully functional. If it is evaluated before the program is fully under
way, its beneficial effects may be substantially underestimated. It is also
difficult to discern when that point has been achieved. The ICDMP’s
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initial nurse care management caseload goals had not been reached by the
end of the first year. Was the program not at full capacity, or had the goals
been unrealistic? Beyond the evaluation of the ICDMP itself there are
additional considerations; a state that assembles a program may generate
healthy ripple effects among other insurers, employers, clinicians, and
delivery systems, thereby increasing the societal return on its investment
over time.
Discerning Start-Up versus Steady-State Costs:
Judgment Calls in a “Game of Inches”
Identifying marginal costs can be difficult. The ICDMP had five distinct
cost centers: (1) nurse care management, (2) telephonic care manage-
ment, (3) the information system, (4) the development of materials used
by service providers, and (5) the time spent by Indiana Medicaid staff to
administer the program. Although the OMPP was able to provide the
total resources consumed or amounts paid to the various contractors in
each cost center, these figures had to be adjusted to deal with two sepa-
rate issues. First, some of the resources devoted to the ICDMP in its first
year were needed for the program’s development and not its operation.
Including such one-time start-up costs in the cost analysis would likely
overstate the cost of delivering the program to participants in subsequent
years. Second, the ICDMP may have operated below capacity during its
first year because the participants had to be phased in by region and by
targeted patient groups. Because some of the operating costs are fixed
(i.e., do not change with patient volume), an excess capacity would re-
sult in average costs overstating the true costs of delivering the program
to additional participants in subsequent years. An additional complica-
tion arose with the OMPP’s statewide phase-in of mandatory risk-based
managed care for children, pregnant women, and low-income families
(completed in 2005). As that phase-in took effect, the asthma disease
management for children in the ICDMP became the responsibility of
the Medicaid managed care organizations.
For these reasons, we supplemented the cost data from OMPP with
additional information provided by the contractors. We asked the fiscal
officers or organizational leaders of each of these five cost centers to
estimate the total amount of resources the ICDMP consumed between
July 1, 2003, and May 31, 2005, to distinguish between one-time start-
up costs (e.g., office equipment) and recurring operational costs. We also
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asked them to divide recurring operational costs: those that were affected
by patient volume (variable costs like nurses’ salaries and benefits) versus
those that, while recurring annually, do not change with patient volume
(fixed costs like insurance). Members of the evaluation team met with
the fiscal officers to explain the differences between these cost types and
to make sure that the different providers used consistent algorithms for
allocating the costs. At this writing, the cost analyses of the ICDMP are
in progress.
Data: Imperfections and Competing Priorities
Evaluations use data from several sources, each of which presents chal-
lenges. Our evaluation uses data from claims, an electronic medical
records system, telephone center logs, and self-reported data from prac-
tices in the learning collaboratives. Claims data can be incomplete and
inaccurate. State-of-the-art electronic medical records data also have lim-
itations. Matching clinical and claims data can bring to light unexpected
problems: fewer than 15 percent of A1C tests assayed at the point of
care and fewer than 40 percent of all A1C tests could be matched to a
specific Medicaid claim for A1C testing. Still, this ability to compare
administrative and clinical data adds depth to the evaluation. The prac-
tices’ self-reported data to the collaboratives were uneven: small- and
large-group practices had different challenges in reporting, and some
practices dropped out entirely. The collection of new data by nurse care
managers and telephone care coordinators, as well as permanent stor-
age of these data in the decision support system, competes with other
priorities in the setting of scarce program resources and personnel.
Generalizability: Difficult for a Multifaceted
Intervention with Complex Data
The results of this evaluation could be difficult to generalize. The novel
nature of this tailored chronic disease management program, the id-
iosyncratic characteristics of the practice environment in Indiana, and
the uniqueness of the Regenstrief Medical Records System may limit the
generalizability of our findings to other settings. A comprehensive, com-
puterized medical records system may be available in few places other
than Indianapolis. The complex assembly required for success may not
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permit a straightforward transfer of this program to other states. Still,
designers of other “assemble-not-buy” programs may find the various
evaluation findings and lessons learned in Indiana to be useful.
The Precarious Stance of the Evaluator: Arbiter,
Advocate, or Apparatchik?
Consider the role of the evaluator. The Indiana OMPP’s decision to seek
an independent evaluation is distinctive and commendable. The stance
adopted by the university team in an effort to reduce role confusion is
to provide the best available information for the OMPP managers—the
university provides decision support; the state makes the decisions. But
the line between decision support and policy advocacy is sometimes not
easily drawn. The university-based teams (Regenstrief Institute, as well
as the MacColl Institute) bring an a priori perspective that disease man-
agement initiatives are worthy endeavors. Working closely with the state
on some specific aspects of the program’s development (such as call scripts
for telephonic care management) as well as on the program’s evaluation,
allegiances naturally strengthen. On the one hand, such allegiances are
essential to a practical evaluation (Finkelstein et al. 2002). For states that
choose a large-scale, “assemble” approach, one of the necessary ingredi-
ents for success might be effective collaboration between government
and university teams. On the other hand, this role carries with it the
danger of loss of objectivity—the independent evaluator as either advo-
cate or “hired gun.” Both the state managers and the university-based
team would like disease management to prove effective. Some processes
that might help address this challenge include separating university per-
sonnel who work on the program’s development from those who work on
its evaluation (an approach that is not always feasible) or submitting the
evaluation results for publication in a peer-reviewed journal (a process
that both the state and the university support).
Conclusion
Rather than buy a chronic disease management program from a national
program vendor, the state of Indiana decided to assemble and manage its
own initiative. Disease management on a large scale presents challenges
but also significant opportunities to improve self-management, quality
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of care, and health for populations with chronic illnesses. The challenges
in program development and evaluation are not intractable. The inno-
vative program in Indiana—in its successes and challenges—can offer
valuable information to other states, whether they “build,” “buy,” or
“assemble” a disease management program. The randomized controlled
trial component and the combined use of Medicaid and electronic med-
ical records data in Indianapolis will strengthen the evaluation of the
ICDMP. We hope that by describing the ICDMP and explaining some
of its principal challenges, we will provide others with a sense of the
territory we have explored and the rocky fields we are attempting to till.
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